Therapeutic Asset Ratings

Immunoglobulin G1 [301-alanine,de-C-terminal-lysine], anti-(human CD73 antigen) (human-Mus musculus monoclonal INCA00186 ?1-chain), disulfide with human-Mus musculus monoclonal INCA00186 ?-chain, dimer

Immunoglobulin G1, anti-(human CC chemokine receptor CCR8) (human monoclonal BAY 3375968 ?1-chain), disulfide with human monoclonal BAY 3375968 ?-chain, dimer

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE; EC=2.7.10.1)); HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO THE PYRROLOBENZODIAZEPINE (PDB) DIMER, SG3199; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-451) (VH HUMANIZED (HOMO SAPIENS IGHV3-30*03 (93%)-(IGHD)-IGHJ4*01 (92%)) (8.8.15) (1-122) HOMO SAPIENS IGHG1*03 (CH1(R97>K(219)), CH3(K107>DEL(452))) (123-451)), (225-215')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-215') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-11*01 (84%)-IGKJ4*01 (91%))(7.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (109'-215')); DIMER (231-231'':234-234'')-BISDISULFIDE, PRODUCED IN CHINESE CHO CELLS, GLYCOFORM ALFA; CONJUGATED ON THE TWO GLYCOENGINEERED ASN-302 AND ASN-302'', VIA A SPACER AND CLEAVABLE VALYL-ALANYL LINKER, TO THE CYTOTOXIC PYRROLOBENZODIAZEPINE (PBD) DIMER, SG3199

Inavolisib

Inca33890

Incb106385

Indoximod

ism8207

Jmkx005425

Jnj-87890387

js019

js107

jyp0035 experimental drug treatment

kc1036

kh617

kqb368

lt-010391

m3t01

m7437

m9446

Mechanobiologically Reprogrammed Macrophage-Derived Exosomes

Metarrestin

mgc028

mk-0472

mk-6204 for